Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

130.61 -1.18 (-0.90%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
42 43 Next >
Behind the Scenes of Abbott Laboratories's Latest Options Trends
Via Benzinga
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
ABT earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Abbott Laboratories Dividend Stock Analysis
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the... 
Via Talk Markets
Abbott Laboratories Unusual Options Activity
Via Benzinga
Analyst Ratings For Abbott Laboratories
Via Benzinga
Abbott Laboratories Outlook is Healthy: Buy the Dip
Abbott Laboratories had a steady quarter, producing growth, better-than-expected earnings, and raising the guidance. Analysts see the stock moving higher. 
Via MarketBeat
Exposures COVID-19
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth. 
Via Talk Markets
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell. 
Via Investor's Business Daily
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO... 
Via Benzinga
Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point
U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bullish market watchers pointed out there could be an... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For April 17, 2024
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share on revenue of $6.13 billion. 
Via Benzinga
Investor Optimism Decreases; Dow Ends 6-Session Losing Streak
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased... 
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Johnson & Johnson is as Cheap as it’s Going to Get
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely. 
Via MarketBeat
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
3 Buy Rated Stocks To Consider As Earnings Approach
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation. 
Via Talk Markets
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. 
Via Benzinga
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end? 
Via Investor's Business Daily
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income. 
Via The Motley Fool
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods. 
Via InvestorPlace
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over 
Via Benzinga
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks. 
Via The Motley Fool
3 Top Dividend Stocks to Buy in April 2024
Each of these high-quality stocks looks like a buy. 
Via The Motley Fool
Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW). 
Via Talk Markets
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life.... 
Via Benzinga
Exposures Product Safety
DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People 
Via MarketBeat
Russell 2000 Index Best And Worst Performing Stocks Of 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback